PHT Live – Hot Flashes, Going Beyond Hormone Replacement Therapy

To Watch Live Hangout hit the play button
Have questions?  Ask below!

This week we have another fantastic broadcast!  We will be discussing the topic “hot flashes, go beyond hormone replacement therapy.” 

Many with hot flashes, including doctors, are faced with the challenge of using hormone replacement therapy to alleviate their symptoms.  Hormone replacement therapy typically consists of taking estrogen derived from a horse and a progesterone derivative.  Unfortunately, chronic administration of these hormones has been associated with increased risk of breast cancer, stroke, and dementia. 

Therefore, we will be discussing how to approach hot flashes without the use of medications.  We will be discussing other hormones of interest  that may be significantly safer to use, as well as the effects of the stress response and blood sugar on hot flashes.

Please enjoy, and send us any questions!  

 

References:

1. What do we know about metabolic syndrome in adolescents with PCOS?
C?r?k DA, Dilbaz B.
J Turk Ger Gynecol Assoc. 2014 Mar 1;15(1):49-55. eCollection 2014. Review.
PMID: 24790517 [PubMed – as supplied by publisher]
Related citations
2. Past hormone therapy in older women: does the brain recover from adverse effects?
Kantarci K, Maki PM.
Neurology. 2014 Feb 4;82(5):380-1. doi: 10.1212/WNL.0000000000000093. Epub 2014 Jan 2.
PMID: 24384642 [PubMed – indexed for MEDLINE]
Related citations
3. Mechanism of hot flashes.
Vilar-González S, Pérez-Rozos A, Cabanillas-Farpón R.
Clin Transl Oncol. 2011 Mar;13(3):143-7. doi: 10.1007/s12094-011-0633-x. Review.
PMID: 21421458 [PubMed – indexed for MEDLINE]
Related citations
4. DHEA, important source of sex steroids in men and even more in women.
Labrie F.
Prog Brain Res. 2010;182:97-148. doi: 10.1016/S0079-6123(10)82004-7.
PMID: 20541662 [PubMed – indexed for MEDLINE]
Related citations
5. Endocrine biomarkers and symptom clusters during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women’s Health Study.
Woods NF, Cray L, Mitchell ES, Herting JR.
Menopause. 2014 Apr 28. [Epub ahead of print]
PMID: 24781854 [PubMed – as supplied by publisher]
Related citations
6. Hot flashes and fatigue relieved by metformin.
Maudar V, Winters SJ, Villafuerte BC.
Endocr Pract. 2009 Jan-Feb;15(1):30-4.
PMID: 19211394 [PubMed – indexed for MEDLINE]
Related citations
7. Menopause and hypothalamic-pituitary sensitivity to estrogen.
Weiss G, Skurnick JH, Goldsmith LT, Santoro NF, Park SJ.
JAMA. 2004 Dec 22;292(24):2991-6. Erratum in: JAMA. 2007 Jul 18;298(3):288. JAMA. 2005 Jan 12;293(2):163.
PMID: 15613667 [PubMed – indexed for MEDLINE]
Related citations
8. Menopausal hot flash frequency changes in response to experimental manipulation of blood glucose.
Dormire SL, Reame NK.
Nurs Res. 2003 Sep-Oct;52(5):338-43.
PMID: 14501548 [PubMed – indexed for MEDLINE]
Related citations
9. Hepatic dysfunction in development of menopausal hot flushes?
Garai J.
Med Hypotheses. 2002 Jun;58(6):535-9.
PMID: 12323128 [PubMed – indexed for MEDLINE]
Related citations
10. Estrogen improves impaired musculocutaneous vascular adrenergic reactivity in pharmacologically ovariectomized rats: a potential peripheral mechanism for hot flashes?
Acs N, Vajo Z, Demendi C, Nádasy G, Monos E, Székács B.
Gynecol Endocrinol. 2001 Feb;15(1):68-73.
PMID: 11293928 [PubMed – indexed for MEDLINE]
Related citations
11. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
Simon J, Klaiber E, Wiita B, Bowen A, Yang HM.
Menopause. 1999 Summer;6(2):138-46.
PMID: 10374221 [PubMed – indexed for MEDLINE]
Related citations
12. Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes.
Freedman RR.
Fertil Steril. 1998 Aug;70(2):332-7.
PMID: 9696230 [PubMed – indexed for MEDLINE]
Related citations
13. Biophysical and endocrine-metabolic changes during menopausal hot flashes: increase in plasma free fatty acid and norepinephrine levels.
Cignarelli M, Cicinelli E, Corso M, Cospite MR, Garruti G, Tafaro E, Giorgino R, Schonauer S.
Gynecol Obstet Invest. 1989;27(1):34-7.
PMID: 2920971 [PubMed – indexed for MEDLINE]
Related citations
14. Opioid-induced androgen deficiency (OPIAD).
Smith HS, Elliott JA.
Pain Physician. 2012 Jul;15(3 Suppl):ES145-56. Review.
PMID: 22786453 [PubMed – indexed for MEDLINE] Free Article
Related citations
15. Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions.
Pachman DR, Jones JM, Loprinzi CL.
Int J Womens Health. 2010 Aug 9;2:123-35.
PMID: 21072305 [PubMed] Free PMC Article
Related citations
16. Natural hormone therapy for menopause.
Mahmud K.
Gynecol Endocrinol. 2010 Feb;26(2):81-5. doi: 10.3109/09513590903184134.
PMID: 19995152 [PubMed – indexed for MEDLINE]
Related citations
17. Dehydroepiandrosterone for the treatment of hot flashes: a pilot study.
Barton DL, Loprinzi C, Atherton PJ, Kottschade L, Collins M, Carpenter P, Adjei A, Rummans TA, Shanafelt T, Christensen B, Sloan J.
Support Cancer Ther. 2006 Jan 1;3(2):91-7. doi: 10.3816/SCT.2006.n.004.
PMID: 18632445 [PubMed]
Related citations
18. Alternative therapies for postmenopausal women.
Speroff L.
Int J Fertil Womens Med. 2005 May-Jun;50(3):101-14. Review.
PMID: 16279503 [PubMed – indexed for MEDLINE]
Related citations
19. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition.
Randolph JF Jr, Sowers M, Bondarenko I, Gold EB, Greendale GA, Bromberger JT, Brockwell SE, Matthews KA.
J Clin Endocrinol Metab. 2005 Nov;90(11):6106-12. Epub 2005 Sep 6.
PMID: 16144949 [PubMed – indexed for MEDLINE]
Related citations
20. [Therapy with dehidroepiandrosterone improves symptoms in perimenopausal women].
Hernández Valencia M, Angeles L, Saucedo R, Basurto L, Zárate A.
Ginecol Obstet Mex. 2005 May;73(5):245-9. Spanish.
PMID: 21966763 [PubMed – indexed for MEDLINE]
Related citations
21. Treatment with a gonadotropin-releasing hormone agonist in acne or idiopathic hirsutism.
Faloia E, Filipponi S, Mancini V, Morosini P, De Pirro R.
J Endocrinol Invest. 1993 Oct;16(9):675-7.
PMID: 8282961 [PubMed – indexed for MEDLINE]
Related citations
22. Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease.
Steingold K, De Ziegler D, Cedars M, Meldrum DR, Lu JK, Judd HL, Chang RJ.
J Clin Endocrinol Metab. 1987 Oct;65(4):773-8.
PMID: 3116031 [PubMed – indexed for MEDLINE]
Related citations

Leave a Comment

Your email address will not be published. Required fields are marked *

*

This site uses Akismet to reduce spam. Learn how your comment data is processed.